| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,587 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,594 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,070 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,374 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,032 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
607 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7375073 |
Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
May. 20, 2008 |
| 7374901 |
Method of analyzing coenzyme Q-10 and two-electron reduction product thereof and analysis system |
May. 20, 2008 |
| 7374892 |
Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
May. 20, 2008 |
| 7374889 |
Human sphingosine-1-phosphate phosphatase and inhibition methods |
May. 20, 2008 |
| 7374769 |
Method for treating a trigeminal neuralgia by peripheral administration of a neurotoxin |
May. 20, 2008 |
| 7374764 |
CD33-like protein |
May. 20, 2008 |
| 7374758 |
Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof |
May. 20, 2008 |
| 7374757 |
Modified chimeric polypeptides with improved pharmacokinetic properties |
May. 20, 2008 |
| 7371734 |
Oligonucleotide compositions and their use for the modulation of immune responses |
May. 13, 2008 |
| 7371728 |
Prostate-specific antigen probes for optical imaging |
May. 13, 2008 |
| 7371726 |
Neutralizing GDF8 epitope-based growth enhancing vaccine |
May. 13, 2008 |
| 7371725 |
Spondyloarthropathies |
May. 13, 2008 |
| 7371724 |
KAPREKY peptidomimetics and analogues thereof |
May. 13, 2008 |
| 7371723 |
Therapeutic agents comprising pro-apoptotic proteins |
May. 13, 2008 |
| 7371722 |
Pharmaceutical preparations and medicine capable of generating and/or containing thrombin |
May. 13, 2008 |
| 7371721 |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
May. 13, 2008 |
| 7371720 |
Cationic peptides of the phylloseptin family isolated from the skin secretion of Phyllomedusa hypochondrialis |
May. 13, 2008 |
| 7371719 |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
May. 13, 2008 |
| 7371543 |
Factor VII or VIIa-like molecules |
May. 13, 2008 |
| 7371418 |
Method for controlling the yield and purity of proteinase inhibitor II during extraction |
May. 13, 2008 |
| 7371394 |
Antigenic composition of a Pseudomonas aeruginosa protein |
May. 13, 2008 |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7371375 |
Protein |
May. 13, 2008 |
| 7371372 |
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection |
May. 13, 2008 |
| 7371370 |
Methods of using G-CSF analog compositions |
May. 13, 2008 |
| 7368431 |
Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
May. 6, 2008 |
| 7368421 |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
May. 6, 2008 |
| 7368420 |
Akt compositions for enhancing survival of cells |
May. 6, 2008 |
| 7368127 |
Biomedical devices with peptide containing coatings |
May. 6, 2008 |
| 7368119 |
Compositions and methods for WT1 specific immunotherapy |
May. 6, 2008 |
| 7368106 |
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state |
May. 6, 2008 |
| 7365054 |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
Apr. 29, 2008 |
| 7365052 |
Tendon-inducing methods |
Apr. 29, 2008 |
| 7365051 |
Compounds with improved cartilage-inducing and/or bone-inducing activity |
Apr. 29, 2008 |
| 7365050 |
Methods for modulating a drug-related effect or behavior |
Apr. 29, 2008 |
| 7365049 |
Afamin-containing compositions and methods of use |
Apr. 29, 2008 |
| 7365047 |
Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
Apr. 29, 2008 |
| 7364910 |
Methods of inducing ovulation |
Apr. 29, 2008 |
| 7364887 |
Use of PAK inhibitor for the treatment of a joint disease |
Apr. 29, 2008 |
| 7364741 |
Peptides of human Papilloma virus for use in human T cell response inducing compositions |
Apr. 29, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7364722 |
Pharmaceutical and cosmetic compositions comprising plgf-1 |
Apr. 29, 2008 |
| 7361635 |
Simultaneous modulation of multiple genes |
Apr. 22, 2008 |
| 7361634 |
Pain-sensitive therapeutic wound dressings |
Apr. 22, 2008 |
| 7361633 |
Screening method and anti-tumor drug candidate obtained therefrom |
Apr. 22, 2008 |
| 7361358 |
Treatment of a facial pain by peripheral administration of a neurotoxin |
Apr. 22, 2008 |
| 7358228 |
Methods of treating pain using neurotrophic factors |
Apr. 15, 2008 |
| 7358227 |
Pharmaceutical compositions comprising bone morphogenetic protein monomers for inhibiting bone formation |
Apr. 15, 2008 |
| 7358226 |
Ultrasonic concentration of drug delivery capsules |
Apr. 15, 2008 |
| 7358225 |
Cloning and recombinant production of CRF receptor(s) |
Apr. 15, 2008 |
|
|
|
